On-Demand Webinar
Advancing neuroimmunology research and therapeutic development requires more than identifying biomarkers—it requires the ability to measure them with the sensitivity and precision needed to translate biological signals into meaningful research and clinical insights.
In this on-demand webinar, Quanterix and XTalks explore how ultrasensitive biomarker quantification is supporting neuroimmunology research across translational and clinical development programs. Discover how highly sensitive digital immunoassay technologies can enable the measurement of established and emerging neuroimmune biomarkers in cerebrospinal fluid (CSF), blood and other accessible matrices.
Explore the role of key neuroimmune biomarkers
The webinar examines the application of biomarkers including:
- Neurofilament Light Chain (NfL) — a marker of neuroaxonal injury
- Glial Fibrillary Acidic Protein (GFAP) — a marker associated with astrocytic damage
- Soluble TREM2 (sTREM2) — a marker of microglial activation
- YKL-40 — a biomarker associated with neuroinflammatory processes
These biomarkers are increasingly being investigated across drug development and clinical research to support disease characterization, patient monitoring, treatment response evaluation and therapeutic development.
What you’ll learn
- How ultrasensitive biomarker measurement can support neuroimmunology research and therapeutic development
- How NfL, GFAP and sTREM2 are being applied in patient stratification, disease monitoring and treatment response evaluation
- Strategies for measuring low-abundance proteins and cytokines with high sensitivity and precision
- The role of blood- and CSF-based biomarkers in translational research and clinical development
- How biomarker measurements can be translated into actionable insights to strengthen clinical studies and therapeutic programs
Watch the webinar on demand
Once registered, you’ll gain access to the full on-demand webinar recording and can watch at your convenience.
Related Posts
Accelerate Building Custom Spatial Proteomic Panels for New Biological Insights
Underdiagnosis of Alzheimer’s disease pathology in patients with cardiovascular disease
Decoding Neurodegeneration: High-plex Spatial Proteomics Reveal Distinct Cell Phenotypes and Pathological Signatures in Parkinson’s and Alzheimer’s Disease
In this webinar, Dr. Birgitt Schuele, Associate Professor (Research) of Pathology at Stanford University, showcases how ultrahigh-plex spatial proteomics is being used to uncover distinct cell phenotypes and pathological signatures…
Understanding the Brain: Advancing Neurodegeneration Research with Ultrahigh-Plex Spatial Proteomics
In this webinar, learn how ultrahigh-plex spatial phenotyping has been applied to neurodegenerative disease research.
p-Tau 205 and p-Tau 212: Emerging Biomarkers for Alzheimer’s Disease Research
Spatial Awareness: AI-powered Profiling of Trillions of Immune Cell Distribution Data Points Reveals Key Predictors of Cancer Recurrence Risk
This webinar highlights a groundbreaking study recently published as a Nature cover story (April 2025). Dr. Joe Yeong will describe how a pre-designed analytical framework—driven by well-defined clinical and scientific…
Multimodal Single-Cell Spatial Transcriptomics and Proteomics to Uncover the Biological Processes Driving Immunotherapy Response and Resistance in Renal Cancer
In this webinar, Dr. Anne-Laure Cattin from the Cancer Dynamics Laboratory at The Francis Crick Institute in London, will share her research on kidney cancer, focusing on the integration of…
Tertiary Lymphoid Structures in Cancer Immunotherapy: Insights and Perspectives
Tertiary lymphoid structures (TLS) have emerged as critical components of the tumor microenvironment, influencing immune responses and clinical outcomes in cancer.